Literature DB >> 6813895

Time course of plasma drug levels during once-daily oral administration of clomipramine.

J E Burch, D M Shaw, A Michalakeas, B Karajgi, S G Roberts, M A Raddats.   

Abstract

Fourteen depressed in-patients were treated with 150 mg clomipramine (CLO) daily, given as one oral dose. Using a gas-chromatographic method, concentrations of CLO and desmethyl clomipramine (DMCLO) were determined in plasma samples taken at frequent intervals during 24 h. The plasma level of each compound 12 h after the dose correlated well with the average value in the same patient, calculated over the whole 24-h period. Levels at other times gave poorer correlations, and at 24 h it was particularly poor. Plasma DMCLO concentrations were usually maximum 4-6 h after the dose. The ratios of maximum to minimum levels averaged only 1.31 +/- 0.15 SD. Peak CLO levels occurred 3 or 4 h after the dose. Maximum; minimum ratios averaged 2.72 +/- 0.73 SD, contrasting with the much smaller fluctuations of plasma nortriptyline (NT) levels observed in patients given this drug once daily. The difference is not due to a shorter half-life of CLO, but to the absorption and/or distribution behaviour of the two drugs. Although not fully understood, this difference between tertiary and secondary amines appears to hold generally among the tricyclic antidepressants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813895     DOI: 10.1007/bf00432768

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  The effects of some pharmacologically active amines on the rate of gastric emptying in rats.

Authors:  J W Bridges; J G Dent; P Johnson
Journal:  Life Sci       Date:  1976-01-01       Impact factor: 5.037

2.  Sampling time, dosage schedule, and nortriptyline plasma levels.

Authors:  V E Ziegler; J W Knesevich; L T Wylie; J T Biggs
Journal:  Arch Gen Psychiatry       Date:  1977-05

3.  Single dose studies with clomipramine in normal subjects.

Authors:  R B Jones; D K Luscombe
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

4.  Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.

Authors:  R P Hullin
Journal:  Postgrad Med J       Date:  1980       Impact factor: 2.401

5.  Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography.

Authors:  H G Westenberg; R A De Zeeuw; H De Cuyper; H M Van Praag; J Korf
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

6.  No circadian effect on nortriptyline kinetics in man.

Authors:  S Nakano; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

7.  Single versus divided daily dosages of clomipramine. Plasma concentration and clinical effect.

Authors:  S J Dencker; A Nagy
Journal:  Acta Psychiatr Scand       Date:  1979-03       Impact factor: 6.392

8.  A clinical trial comparing sustained release amitryptyline (Saroten Retard) and conventional amitriptyline tablets (Saroten) in endogenously depressed patients with simultaneous determination of serum levels of amitryptyline and nortriptyline.

Authors:  P Liisberg; H Mose; A Amdisen; A Jørgensen; H E Petersen
Journal:  Acta Psychiatr Scand       Date:  1978-05       Impact factor: 6.392

9.  Plasma concentrations of amitriptyline during single nightly and thrice daily administration. Cross-over study.

Authors:  D De Maio; F Drago; P Nielsen; V Ascalone; M Cisternino
Journal:  Arzneimittelforschung       Date:  1980

10.  Amitriptyline pharmacokinetics. Single doses of Lentizol compared with ordinary amitriptyline tablets.

Authors:  J E Burch; R P Hullin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  4 in total

1.  Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Authors:  M Gex-Fabry; A E Balant-Gorgia; L P Balant; G Garrone
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 3.  Obsessive-compulsive disorder in elderly patients.

Authors:  C W Jackson
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

4.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.